
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $105.9B | $157.7B | $241.4B | $210.1B | $189.2B | |
Revenue Growth (YoY) | -33.5% | 48.89% | 53.03% | -12.95% | -9.97% | |
Cost of Revenues | $95.8B | $134.9B | $186.3B | $162.1B | $158.9B | |
Gross Profit | $10.2B | $22.9B | $55.1B | $48.1B | $30.2B | |
Gross Profit Margin | 9.61% | 14.49% | 22.82% | 22.88% | 15.98% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.4B | $11.9B | $13.4B | $16.8B | $16.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $10.8B | $12.2B | $13.6B | $17B | $16.6B | |
Operating Income | -$573M | $10.7B | $41.4B | $31B | $13.6B | |
Net Interest Expenses | $2.4B | $2.1B | $1.5B | $1.9B | $1.7B | |
EBT. Incl. Unusual Items | -$24.9B | $15.2B | $15.4B | $23.7B | $6.8B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$4.2B | $6.7B | $16.8B | $7.9B | $5.6B | |
Net Income to Company | -$24.9B | $15.2B | $15.4B | $23.7B | $6.8B | |
Minority Interest in Earnings | $424M | -$922M | -$1.1B | -$641M | -$848M | |
Net Income to Common Excl Extra Items | -$20.3B | $7.6B | -$2.5B | $15.2B | $381M | |
Basic EPS (Cont. Ops) | -$6.03 | $2.25 | -$0.79 | $5.27 | $0.14 | |
Diluted EPS (Cont. Ops) | -$6.03 | $2.24 | -$0.79 | $5.15 | $0.14 | |
Weighted Average Basic Share | $3.4B | $3.4B | $3.2B | $2.9B | $2.7B | |
Weighted Average Diluted Share | $3.4B | $3.4B | $3.2B | $3B | $2.8B | |
EBITDA | -$7B | $32.5B | $32.3B | $43.5B | $28B | |
EBIT | -$21.9B | $17.7B | $18B | $27.6B | $11.4B | |
Revenue (Reported) | $105.9B | $157.7B | $241.4B | $210.1B | $189.2B | |
Operating Income (Reported) | -$573M | $10.7B | $41.4B | $31B | $13.6B | |
Operating Income (Adjusted) | -$21.9B | $17.7B | $18B | $27.6B | $11.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $34.5B | $49.3B | $56.2B | $48.9B | $46.9B | |
Revenue Growth (YoY) | 11.53% | 42.6% | 14.06% | -13% | -4.04% | |
Cost of Revenues | $26.1B | $38.9B | $40.4B | $39.1B | $38.5B | |
Gross Profit | $8.4B | $10.3B | $15.8B | $9.8B | $8.4B | |
Gross Profit Margin | 24.35% | 21% | 28.13% | 20.03% | 18% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.6B | $3.1B | $3.7B | $4.2B | $4.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $2.7B | $3.2B | $3.9B | $4.5B | $4.5B | |
Operating Income | $5.7B | $7.2B | $12B | $5.3B | $3.9B | |
Net Interest Expenses | $647M | $450M | $537M | $653M | $884M | |
EBT. Incl. Unusual Items | $6.5B | -$17.5B | $11.8B | $4.6B | $3.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6B | $2.5B | $3.4B | $2.2B | $2.1B | |
Net Income to Company | $6.5B | -$17.5B | $11.8B | $4.6B | $3.1B | |
Minority Interest in Earnings | -$233M | -$314M | -$204M | -$146M | -$295M | |
Net Income to Common Excl Extra Items | $4.7B | -$20.4B | $8.2B | $2.3B | $687M | |
Basic EPS (Cont. Ops) | $1.38 | -$6.27 | $2.76 | $0.81 | $0.26 | |
Diluted EPS (Cont. Ops) | $1.37 | -$6.27 | $2.70 | $0.80 | $0.26 | |
Weighted Average Basic Share | $3.4B | $3.3B | $3B | $2.8B | $2.6B | |
Weighted Average Diluted Share | $3.4B | $3.3B | $3B | $2.9B | $2.7B | |
EBITDA | $10.7B | -$13.2B | $16.5B | $9.9B | $8.6B | |
EBIT | $7.3B | -$16.9B | $12.7B | $5.7B | $4.5B | |
Revenue (Reported) | $34.5B | $49.3B | $56.2B | $48.9B | $46.9B | |
Operating Income (Reported) | $5.7B | $7.2B | $12B | $5.3B | $3.9B | |
Operating Income (Adjusted) | $7.3B | -$16.9B | $12.7B | $5.7B | $4.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $109.5B | $172.5B | $248.3B | $202.8B | $187.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $91.3B | $147.7B | $187.8B | $160.8B | $158.3B | |
Gross Profit | $18.2B | $24.8B | $60.6B | $42.1B | $28.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $10.3B | $12.4B | $14.1B | $17.2B | $16.6B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $10.6B | $12.6B | $14.3B | $18.4B | $17.4B | |
Operating Income | $7.6B | $12.1B | $46.2B | $23.7B | $11.5B | |
Net Interest Expenses | $2.3B | $1.9B | $1.6B | $2.1B | $2B | |
EBT. Incl. Unusual Items | -$13.8B | -$8.9B | $44.8B | $16.5B | $5.3B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.4B | $7.6B | $17.7B | $6.7B | $5.5B | |
Net Income to Company | -$13.8B | -$8.9B | $44.8B | $16.5B | $5.3B | |
Minority Interest in Earnings | $171M | -$1B | -$1B | -$583M | -$997M | |
Net Income to Common Excl Extra Items | -$11.3B | -$17.5B | $26.1B | $9.3B | -$1.2B | |
Basic EPS (Cont. Ops) | -$3.35 | -$5.40 | $8.50 | $3.25 | -$0.45 | |
Diluted EPS (Cont. Ops) | -$3.36 | -$5.41 | $8.35 | $3.18 | -$0.46 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $9.6B | $8.7B | $62.1B | $37.5B | $27.1B | |
EBIT | -$10.9B | -$6.4B | $47.6B | $20.6B | $10.2B | |
Revenue (Reported) | $109.5B | $172.5B | $248.3B | $202.8B | $187.2B | |
Operating Income (Reported) | $7.6B | $12.1B | $46.2B | $23.7B | $11.5B | |
Operating Income (Adjusted) | -$10.9B | -$6.4B | $47.6B | $20.6B | $10.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $34.5B | $49.3B | $56.2B | $48.9B | $46.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $26.1B | $38.9B | $40.4B | $39.1B | $38.5B | |
Gross Profit | $8.4B | $10.3B | $15.8B | $9.8B | $8.4B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.6B | $3.1B | $3.7B | $4.2B | $4.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $2.7B | $3.2B | $3.9B | $4.5B | $4.5B | |
Operating Income | $5.7B | $7.2B | $12B | $5.3B | $3.9B | |
Net Interest Expenses | $647M | $450M | $537M | $653M | $884M | |
EBT. Incl. Unusual Items | $6.5B | -$17.5B | $11.8B | $4.6B | $3.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6B | $2.5B | $3.4B | $2.2B | $2.1B | |
Net Income to Company | $6.5B | -$17.5B | $11.8B | $4.6B | $3.1B | |
Minority Interest in Earnings | -$233M | -$314M | -$204M | -$146M | -$295M | |
Net Income to Common Excl Extra Items | $4.7B | -$20.4B | $8.2B | $2.3B | $687M | |
Basic EPS (Cont. Ops) | $1.38 | -$6.27 | $2.76 | $0.81 | $0.26 | |
Diluted EPS (Cont. Ops) | $1.37 | -$6.27 | $2.70 | $0.80 | $0.26 | |
Weighted Average Basic Share | $3.4B | $3.3B | $3B | $2.8B | $2.6B | |
Weighted Average Diluted Share | $3.4B | $3.3B | $3B | $2.9B | $2.7B | |
EBITDA | $10.7B | -$13.2B | $16.5B | $9.9B | $8.6B | |
EBIT | $7.3B | -$16.9B | $12.7B | $5.7B | $4.5B | |
Revenue (Reported) | $34.5B | $49.3B | $56.2B | $48.9B | $46.9B | |
Operating Income (Reported) | $5.7B | $7.2B | $12B | $5.3B | $3.9B | |
Operating Income (Adjusted) | $7.3B | -$16.9B | $12.7B | $5.7B | $4.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $29.2B | $25.9B | $23.3B | $27.7B | $34.4B | |
Short Term Investments | $333M | $280M | $578M | $843M | $165M | |
Accounts Receivable, Net | $12.9B | $22.3B | $28.2B | $25.2B | $21.7B | |
Inventory | $16.9B | $23.7B | $28.1B | $22.8B | $23.2B | |
Prepaid Expenses | $1.3B | $2.5B | $2.1B | $2.5B | $2.6B | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $73B | $92.6B | $107.7B | $104.1B | $102.8B | |
Property Plant And Equipment | $118.9B | $117.2B | $110.3B | $109B | $104.7B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $12.5B | $12.4B | $12B | $12.5B | $14.9B | |
Other Intangibles | $2B | $2.2B | $6B | $5.7B | $5.2B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $267.7B | $287.3B | $288.1B | $280.3B | $282.2B | |
Accounts Payable | $23.2B | $37.3B | $47.2B | $42.4B | $38.6B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $1.9B | $1.7B | $2.1B | $2.7B | $2.7B | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $59.8B | $80.3B | $99B | $86.1B | $82.2B | |
Long-Term Debt | $63.3B | $55.6B | $43.7B | $48.7B | $55.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $182.1B | $196.8B | $205.1B | $194.8B | $203.9B | |
Common Stock | $5.4B | $5.2B | $4.8B | $4.5B | $4.2B | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $71.2B | $75.4B | $67.5B | $70.3B | $59.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $14.3B | $15B | $15.4B | $15.2B | $19.1B | |
Total Equity | $85.6B | $90.4B | $83B | $85.5B | $78.3B | |
Total Liabilities and Equity | $267.7B | $287.3B | $288.1B | $280.3B | $282.2B | |
Cash and Short Terms | $29.5B | $26.2B | $23.9B | $28.6B | $34.5B | |
Total Debt | $72.7B | $61.2B | $46.9B | $52B | $59.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $31.7B | $34.4B | $30.4B | $31.5B | $33.8B | |
Short Term Investments | $216M | $103M | $450M | $615M | $275M | |
Accounts Receivable, Net | $20.1B | $35.6B | $29.4B | $29.9B | $28.5B | |
Inventory | $20.9B | $30.1B | $23.9B | $24.3B | $24.7B | |
Prepaid Expenses | $1.5B | $2.6B | $1.8B | $2.2B | $2.9B | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $78.1B | $120.1B | $99.3B | $101.4B | $101.1B | |
Property Plant And Equipment | $112.9B | $109.9B | $105.7B | $102.7B | $100.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $12.5B | $11.9B | $12B | $12.4B | $14.9B | |
Other Intangibles | $6.1B | $6.4B | $10.3B | $10B | $9.1B | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $269.9B | $295.5B | $278.7B | $275.4B | $281.4B | |
Accounts Payable | $40.7B | $61.2B | $57.9B | $58.6B | $58.8B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $1.9B | $1.7B | $2.2B | $2.6B | $2.7B | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $60.7B | $101.2B | $84.6B | $82.3B | $82.8B | |
Long-Term Debt | $60.9B | $55.4B | $46.1B | $48.3B | $53.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $179.3B | $217B | $191.5B | $190.5B | $203.4B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $14.6B | $15.2B | $15.4B | $15.2B | $19.7B | |
Total Equity | $90.6B | $78.5B | $87.2B | $84.9B | $78B | |
Total Liabilities and Equity | $269.9B | $295.5B | $278.7B | $275.4B | $281.4B | |
Cash and Short Terms | $31.9B | $34.5B | $30.9B | $32.1B | $34B | |
Total Debt | $66.1B | $60.6B | $48.6B | $53B | $58.6B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$24.9B | $15.2B | $15.4B | $23.7B | $6.8B | |
Depreciation & Amoritzation | $14.9B | $14.8B | $14.3B | $15.9B | $16.6B | |
Stock-Based Compensation | $723M | $627M | $795M | $616M | $1.2B | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | $4B | -$7.5B | -$5.5B | $5.6B | $808M | |
Cash From Operations | $12.2B | $23.6B | $40.9B | $32B | $27.3B | |
Capital Expenditures | $12.3B | $10.9B | $12.1B | $14.3B | $15.3B | |
Cash Acquisitions | $3.2B | $3.9B | -$2.4B | -$775M | $1.6B | |
Cash From Investing | -$7.9B | -$5.7B | -$13.7B | -$14.9B | -$13.3B | |
Dividends Paid (Ex Special Dividend) | -$6.3B | -$4.3B | -$4.4B | -$4.8B | -$5B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $14.7B | $7B | $2B | $7.6B | $10.7B | |
Long-Term Debt Repaid | -$12.2B | -$16.8B | -$11.7B | -$3.9B | -$3B | |
Repurchase of Common Stock | -$776M | -$3.2B | -$10B | -$7.9B | -$7.1B | |
Other Financing Activities | $12.4B | $509M | -$336M | -$474M | $3.3B | |
Cash From Financing | $4B | -$18.1B | -$28B | -$13.4B | -$7.3B | |
Beginning Cash (CF) | $22.5B | $31.1B | $30.7B | $29.2B | $33B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $8.3B | -$161M | -$802M | $3.8B | $6.8B | |
Ending Cash (CF) | $31.1B | $30.7B | $29.2B | $33B | $39.3B | |
Levered Free Cash Flow | -$144M | $12.7B | $28.9B | $17.8B | $12B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $6.5B | -$17.5B | $11.8B | $4.6B | $3.1B | |
Depreciation & Amoritzation | $3.4B | $3.7B | $3.9B | $4.2B | $4.2B | |
Stock-Based Compensation | -$46M | $170M | -$22M | $161M | $401M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -$2.8B | -$1.8B | -$3.8B | -$2.1B | -- | |
Cash From Operations | $6.1B | $8.2B | $7.6B | $5B | $2.8B | |
Capital Expenditures | $3B | $2.6B | $3.1B | $3.7B | $3.4B | |
Cash Acquisitions | $2.8B | $222M | $289M | -$213M | -$236M | |
Cash From Investing | $427M | -$1.9B | -$2.8B | -$3.8B | -$3.3B | |
Dividends Paid (Ex Special Dividend) | -$1.1B | -$1.1B | -$1.2B | -$1.2B | -$1.3B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2B | $2B | $2.4B | $2.3B | $54M | |
Long-Term Debt Repaid | -$7B | -$892M | -$799M | -$674M | -$1.4B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $613M | -$80M | -$364M | -$232M | $228M | |
Cash From Financing | -$5.9B | -$2.5B | -$3.6B | -$2.4B | -$5.1B | |
Beginning Cash (CF) | $31.1B | $30.7B | $29.2B | $33B | $39.3B | |
Foreign Exchange Rate Adjustment | -$58M | -$125M | -$14M | -$260M | $106M | |
Additions / Reductions | $623M | $3.9B | $1.3B | -$1.3B | -$5.5B | |
Ending Cash (CF) | $31.7B | $34.4B | $30.4B | $31.5B | $33.8B | |
Levered Free Cash Flow | $3.1B | $5.6B | $4.5B | $1.3B | -$517M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$13.8B | -$8.9B | $44.8B | $16.5B | $5.3B | |
Depreciation & Amoritzation | $14.2B | $15.1B | $14.5B | $16.2B | $16.7B | |
Stock-Based Compensation | $683M | $843M | $603M | $799M | $1.4B | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | $487M | -$6.4B | -$7.5B | $7.3B | -- | |
Cash From Operations | $17.3B | $25.7B | $40.3B | $29.4B | $25.1B | |
Capital Expenditures | $11.6B | $10.5B | $12.6B | $14.9B | $14.9B | |
Cash Acquisitions | $5.5B | $1.2B | -$2.4B | -$1.3B | $1.6B | |
Cash From Investing | -$4.3B | -$8B | -$14.6B | -$15.9B | -$12.7B | |
Dividends Paid (Ex Special Dividend) | -$5.3B | -$4.3B | -$4.5B | -$4.8B | -$5B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $14B | $7B | $2.4B | $7.4B | $8.5B | |
Long-Term Debt Repaid | -$15.5B | -$10.7B | -$11.6B | -$3.8B | -$3.7B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $13B | -$184M | -$620M | -$342M | $3.8B | |
Cash From Financing | $28M | -$14.6B | -$29.1B | -$12.2B | -$10B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $13B | $3.1B | -$3.4B | $1.3B | $2.5B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $5.8B | $15.3B | $27.7B | $14.6B | $10.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $6.5B | -$17.5B | $11.8B | $4.6B | $3.1B | |
Depreciation & Amoritzation | $3.4B | $3.7B | $3.9B | $4.2B | $4.2B | |
Stock-Based Compensation | -$46M | $170M | -$22M | $161M | $401M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -$2.8B | -$1.8B | -$3.8B | -$2.1B | -- | |
Cash From Operations | $6.1B | $8.2B | $7.6B | $5B | $2.8B | |
Capital Expenditures | $3B | $2.6B | $3.1B | $3.7B | $3.4B | |
Cash Acquisitions | $2.8B | $222M | $289M | -$213M | -$236M | |
Cash From Investing | $427M | -$1.9B | -$2.8B | -$3.8B | -$3.3B | |
Dividends Paid (Ex Special Dividend) | -$1.1B | -$1.1B | -$1.2B | -$1.2B | -$1.3B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2B | $2B | $2.4B | $2.3B | $54M | |
Long-Term Debt Repaid | -$7B | -$892M | -$799M | -$674M | -$1.4B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $613M | -$80M | -$364M | -$232M | $228M | |
Cash From Financing | -$5.9B | -$2.5B | -$3.6B | -$2.4B | -$5.1B | |
Beginning Cash (CF) | $31.1B | $30.7B | $29.2B | $33B | $39.3B | |
Foreign Exchange Rate Adjustment | -$58M | -$125M | -$14M | -$260M | $106M | |
Additions / Reductions | $623M | $3.9B | $1.3B | -$1.3B | -$5.5B | |
Ending Cash (CF) | $31.7B | $34.4B | $30.4B | $31.5B | $33.8B | |
Levered Free Cash Flow | $3.1B | $5.6B | $4.5B | $1.3B | -$517M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.